Rapid Influenza Diagnostic Test Market
Rapid Influenza Diagnostic Test Market Study by Immunochromatographic Assays, Immunofluorescence Assays, and Nucleic Acid Amplification Test (NAAT)) from 2024 to 2034
Analysis of Rapid Influenza Diagnostic Test Market Covering 30+ Countries Including Analysis of US, Canada, UK, Germany, France, Nordics, GCC countries, Japan, Korea and many more
Rapid Influenza Diagnostic Test Market Outlook (2024 to 2034)
The global rapid influenza diagnostic test market size is expected to reach a valuation of US$ 1.13 billion in 2024 and expand at a CAGR of 8.7% to be worth US$ 2.61 billion by the end of 2034.
Influenza is a contagious respiratory illness caused by influenza viruses that infect the nose, throat, and also the lungs. This disease can cause mild to severe illness and can lead to death if not treated properly. Most people contract influenza when they breathe in tiny airborne droplets from the coughs or sneezes of someone who has the condition.
One can also contract this flu by touching surfaces contaminated with the virus and then touching their mouth, nose, or eyes. Given the global impact of the COVID-19 pandemic, individuals have become increasingly conscious of their health and are actively monitoring symptoms that could indicate such illnesses. This heightened awareness has driven up the demand for rapid influenza diagnostic test kits, thereby driving market growth.
Key Market Growth Drivers
- The market is benefitting from the increasing awareness of early diagnosis of flu symptoms in the wake of the COVID-19 pandemic. This is contributing to the expansion of the rapid influenza diagnostic test market size.
- Those aged 65 years and older are significantly more affected by this virus. Manufacturers of diagnostic test kits are targeting this demographic and actively analyzing the needs of older individuals to boost their sales.
- Suppliers are aware of the ever-evolving healthcare needs, and this understanding has prompted them to incorporate a range of features into their kits, which is projected to result in a significant increase in sales of rapid influenza diagnostic test kits.
- With a substantial elderly population, China is projected to lead the market in the East Asia region. The market in China is projected to expand at a CAGR of 8.4% from 2024 to 2024, thereby contributing significantly to the rapid influenza diagnostic test market share.
- Sales of rapid influenza test kits are projected to surge during select seasons, including rainy and cold periods, as health issues usually rise during these times.
- Manufacturers in the market are investing in enhancing the design, durability, and quality of these kits with the aim of prolonging their lifespan and enhancing their popularity among consumers.
| Report Attributes | Details |
|---|---|
| Rapid Influenza Diagnostic Test Market Size (2024E) | US$ 1.13 Billion |
| Forecasted Market Value (2034F) | US$ 2.61 Billion |
| Global Market Growth Rate (2024 to 2034) | 8.7% CAGR |
| Canada Market Growth Rate (2024 to 2034) | 8.9% CAGR |
| China Market Value (2034F) | US$ 202 Million |
| North America Market Share (2024E) | 38.3% |
| East Asia Market Share (2034F) | 16.4% |
| Key Companies Profiled | Becton; Abbott Laboratories; Quidel Corporation; Hologic; Thermo Fisher Scientific; Dickinson and Company; Meridian Bioscience Inc.; DiaSorin SpA |
Don't Need a Global Report?
save 40%! on Country & Region specific reports
Which Rapid Influenza Diagnostics Test Kit Market Trends are Significant?
“Increasing Population with Compromised Immune Systems and Related Illnesses”
Demand for rapid influenza diagnostic tests is growing due to an increasing population with compromised immune systems and related illnesses. Human influenza viruses, including type A and B, contribute significantly to the burden of this illness. This raises healthcare expenses and affects quality of life.
- According to the World Health Organization (WHO), seasonal influenza causes approximately 3 to 5 million severe illnesses globally each year.
- The European Centre for Disease Prevention and Control reports that influenza affects 10% to 30% of Europe's population annually. Research findings from October 2020 to July 2021 indicate around 1.3 million cases.
These factors have fueled the adoption of influenza tests among the public, with a large number of individuals purchasing test kits in advance to ensure preparedness during emergencies. The market is projected to continue growing in the future, driven by increasing health concerns, particularly following the COVID-19 pandemic.
“Emphasis on Developing Faster and More Precise Diagnostic Technologies”
Increasing frequency of influenza throughout the world has boosted R&D efforts for improved detection and diagnosis. The majority of research work is focused on creating quicker and more accurate diagnostic technologies for influenza viruses, which is driving market expansion.
- The National Institute of Allergy and Infectious Diseases (NIAID), a division of the National Institutes of Health (NIH), established the Collaborative Influenza Vaccine Innovation Centers (CIVICs) initiative to support a wide range of influenza research efforts. CIVICs is set to receive US$ 51 million in support from the NIAID.
“Advancements in Genomic Technology Facilitating Enhanced Surveillance Capabilities”
The Human Genome Project and breakthroughs in molecular and biomedical technology have generated massive amounts of data, resulting in the creation of several tests and technologies useful for the detection and treatment of influenza infections. These new technologies, which rely on genomic procedures (such as PCR) and proteomics (such as microarray-based detection), aid in the discovery of novel influenza viruses. They also enable better surveillance and quicker detection of infectious illnesses, creating commercial opportunities.
What are the Restraints Hindering Rapid Influenza Diagnostic Test Market Growth?
“Stringent Regulatory Framework Restricting Commercialization of Tests”
Most diagnostic businesses encounter significant challenges in commercializing their tests, including convincing Medicare and private health insurers to pay for them. This is crucial not just for clinicians' decision-making in the practice of evidence-based medicine, but also for obtaining regulatory permission and reimbursement for the tests. In recent years, regulatory approvals for influenza tests have become more demanding, ensuring their effectiveness in identifying all forms of influenza viruses.
“Seasonal Nature of Influenza Leading to Fluctuations in Demand for Diagnostic Testing”
One of the major impediments to market expansion is the seasonal nature of influenza. This causes oscillations in the need for diagnostic testing. Furthermore, demand for influenza diagnostics increases during flu seasons and decreases during off-peak periods. This uncertainty has a long-term negative impact on the influenza diagnostic industry. Disparities in healthcare infrastructure, particularly in underdeveloped and developing countries, also impede the general use of modern diagnostic tools. All of these problems limit the market's expansion.
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
Country-wise Evaluation
The South Korean market is projected to expand at a CAGR of 10.6% from 2024 to 2034. This is attracting test kit suppliers to the East Asia region.
Which Elements in the United States Market are Conducive for Market Growth?
“Robust Healthcare Infrastructure and Enhanced Capabilities in Pharmaceutical Research”
| Attribute | United States |
|---|---|
| Market Value (2024E) | US$ 350 Million |
| Growth Rate (2024 to 2034) | 8.8% CAGR |
| Projected Value (2034F) | US$ 814 Million |
The United States has one of the most comprehensive and complex healthcare ecosystems in the world, complete with cutting-edge medical institutions, labs, and diagnostic centers. This promotes the wider use of novel influenza diagnostic technology, hence accelerating market growth. Aside from that, the country is a center for research and development in the healthcare and pharmaceutical industries. As a result, the United States has emerged as one of the world's major influenza diagnostic markets.
What Makes Japan a Profitable Market for Rapid Influenza Diagnostic Testing Providers?
“Government Investments in Enhancement of Diagnostic Laboratories”
| Attribute | Japan |
|---|---|
| Market Value (2024E) | US$ 67 Million |
| Growth Rate (2024 to 2034) | 9.8% CAGR |
| Projected Value (2034F) | US$ 171 Million |
Japan's enhanced healthcare facilities have created a favorable environment for the growth of the market. The Japanese government's strong commitment to healthcare has led to significant investments in influenza diagnostic laboratories, testing camps, and temporary testing facilities, thereby boosting demand for influenza diagnostics.
Category-wise Insights
Among the end users, the retail pharmacy segment is forecasted to expand at a CAGR of 10% from 2024 to 2034. Market players are collaborating with retail pharmacies to enhance their presence.
Why is Inclusion of Nucleic Acid in Diagnostic Testing Kits Increasing Significantly?
“Molecular Fingerprints of Nucleic Acid Facilitating Identification of Various Viruses”
| Attribute | Nucleic Acid |
|---|---|
| Segment Value (2024E) | US$ 320.2 Million |
| Growth Rate (2024 to 2034) | 10.9% CAGR |
| Projected Value (2034F) | US$ 897.2 million |
Inclusion of nucleic acid in diagnostic test kits is due to its molecular fingerprints, which facilitate the identification of various viral pathogens. This has established nucleic acid as a crucial component for ensuring the effectiveness and efficiency of diagnostic kits. Suppliers are actively seeking cost-effective sources of nucleic acid to enhance the affordability of these kits. The presence of nucleic acid significantly simplifies the detection of diseases like influenza, aiding in the prevention of such harmful chronic illnesses.
Which Sample Type is Widely Preferred for Accurate Testing Outcomes?
“Ease of Use Associated with Nasopharyngeal Swab Driving Preference”
| Attribute | Nasopharyngeal Swab |
|---|---|
| Segment Value (2024E) | US$ 343.3 Million |
| Growth Rate (2024 to 2034) | 9.1% CAGR |
| Projected Value (2034F) | US$ 820.9 Million |
The nasopharyngeal airway is a thin, clear, and flexible tube that is inserted into a patient's nostril. The purpose of NPA is to bypass upper airway obstruction at the level of the nose, nasopharynx, or base of the tongue. It also helps prevent the tongue from falling backward on the pharyngeal wall to prevent obstruction. This sample test is user-friendly and straightforward, making it convenient for people to use and get checked quickly.
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
Business Competition
Key players in the rapid influenza diagnostic test market include Becton, Abbott Laboratories, F. Hoffmann-La Roche AG, Quidel Corporation, Hologic, and Thermo Fisher Scientific, among others. These key stakeholders collaborate to develop a wide array of advanced influenza diagnostic treatments and solutions. They provide influenza diagnostic solutions and technology to various entities such as hospitals, diagnostic laboratories, research and academic institutions, and contract research organizations.
While smaller firms also operate in the market, they typically have a smaller consumer base and marketing capacity. These companies often rely on the innovations of industry giants to incorporate new technology into their products.
- In November 2023, Mylab and Ekincare collaborated to promote NASOVAC-S4, an influenza nasal vaccine. Administered non-invasively and painlessly via the nasal route, it offers an attractive option for corporate employee wellness initiatives.
- In January 2023, Roche announced that the European Commission approved Xofluza for the treatment and prevention of influenza in children aged one year and older. This is the first influenza antiviral with a novel mode of action in almost 20 years, inhibiting virus multiplication quicker than oseltamivir.
Key Segments of Rapid Influenza Diagnostic Test Market Research
-
By Principle :
- Immunochromatographic Assays
- Immunofluorescence Assays
- Nucleic Acid Amplification Test
-
By Test Type :
- Influenza A Test
- Influenza B Test
- Influenza A+B Test
-
By Sample Type :
- Throat Swab
- Nasal Swab
- Nasal Aspirate
- Nasal Wash
- Nasopharyngeal Swab
- Nasopharyngeal Aspirate
- Nasopharyngeal Wash
-
By Region :
- North America
- Latin America
- Europe
- East Asia
- South Asia & Oceania
- Middle East & Africa
Table of Content
- 1. Global Market - Executive Summary
- 2. Global Market Overview
- 3. Market Background and Foundation Data Points
- 4. Global Market Demand (US$ Mn) Analysis 2018 to 2023 and Forecast, 2024 to 2034
- 5. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Principle
- 5.1. Immunochromatographic Assays
- 5.2. Immunofluorescence Assays
- 5.3. Nucleic Acid Amplification Test
- 6. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Test Type
- 6.1. Influenza A Test
- 6.2. Influenza B Test
- 6.3. Influenza A+B Test
- 7. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Sample Type
- 7.1. Throat Swab
- 7.2. Nasal Swab
- 7.3. Nasal Aspirate
- 7.4. Nasal Wash
- 7.5. Nasopharyngeal Swab
- 7.6. Nasopharyngeal Aspirate
- 7.7. Nasopharyngeal Wash
- 8. Global Market Analysis 2018 to 2023 and Forecast 2024 to 2034, By Region
- 8.1. North America
- 8.2. Latin America
- 8.3. Europe
- 8.4. East Asia
- 8.5. South Asia & Oceania
- 8.6. Middle East and Africa (MEA)
- 9. North America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 10. Latin America Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 11. Europe Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 12. East Asia Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 13. South Asia & Oceania Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 14. Middle East and Africa Market Analysis 2018 to 2023 and Forecast 2024 to 2034
- 15. Market Structure Analysis
- 16. Competition Analysis
- 16.1. Becton
- 16.2. Abbott Laboratories
- 16.3. Quidel Corporation
- 16.4. Hologic
- 16.5. Thermo Fisher Scientific
- 16.6. Dickinson and Company
- 16.7. Meridian Bioscience Inc.
- 16.8. DiaSorin SpA
- 17. Assumptions and Acronyms Used
- 18. Research Methodology
Don't Need a Global Report?
save 40%! on Country & Region specific reports
List Of Table
Table 01: Global Market Value (US$ Mn) Analysis, by Principle, 2018 to 2023
Table 02: Global Market Value (US$ Mn) Analysis, by Principle, 2024 to 2034
Table 03: Global Market Value (US$ Mn) Opportunity Analysis, by Principle, 2024 to 2034
Table 04: Global Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 05: Global Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 06: Global Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 07: Global Market Value (US$ Mn) Analysis, by Sample Type, 2018 to 2023
Table 08: Global Market Value (US$ Mn) Analysis, by Sample Type, 2024 to 2034
Table 09: Global Market Value (US$ Mn) Opportunity Analysis, by Sample Type, 2024 to 2034
Table 10: Global Market Value (US$ Mn) Analysis, by Region, 2018 to 2023
Table 11: Global Market Value (US$ Mn) Analysis, by Region, 2024 to 2034
Table 12: Global Market Value (US$ Mn) Opportunity Analysis, by Region, 2024 to 2034
Table 13: North America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 14: North America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 15: North America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 16: North America Market Value (US$ Mn) Analysis, by Principle, 2018 to 2023
Table 17: North America Market Value (US$ Mn) Analysis, by Principle, 2024 to 2034
Table 18: North America Market Value (US$ Mn) Opportunity Analysis, by Principle, 2024 to 2034
Table 19: North America Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 20: North America Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 21: North America Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 22: North America Market Value (US$ Mn) Analysis, by Sample Type, 2018 to 2023
Table 23: North America Market Value (US$ Mn) Analysis, by Sample Type, 2024 to 2034
Table 24: North America Market Value (US$ Mn) Opportunity Analysis, by Sample Type, 2024 to 2034
Table 25: Latin America Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 26: Latin America Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 27: Latin America Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 28: Latin America Market Value (US$ Mn) Analysis, by Principle, 2018 to 2023
Table 29: Latin America Market Value (US$ Mn) Analysis, by Principle, 2024 to 2034
Table 30: Latin America Market Value (US$ Mn) Opportunity Analysis, by Principle, 2024 to 2034
Table 31: Latin America Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 32: Latin America Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 33: Latin America Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 34: Latin America Market Value (US$ Mn) Analysis, by Sample Type, 2018 to 2023
Table 35: Latin America Market Value (US$ Mn) Analysis, by Sample Type, 2024 to 2034
Table 36: Latin America Market Value (US$ Mn) Opportunity Analysis, by Sample Type, 2024 to 2034
Table 37: Europe Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 38: Europe Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 39: Europe Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 40: Europe Market Value (US$ Mn) Analysis, by Principle, 2018 to 2023
Table 41: Europe Market Value (US$ Mn) Analysis, by Principle, 2024 to 2034
Table 42: Europe Market Value (US$ Mn) Opportunity Analysis, by Principle, 2024 to 2034
Table 43: Europe Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 44: Europe Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 45: Europe Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 46: Europe Market Value (US$ Mn) Analysis, by Sample Type, 2018 to 2023
Table 47: Europe Market Value (US$ Mn) Analysis, by Sample Type, 2024 to 2034
Table 48: Europe Market Value (US$ Mn) Opportunity Analysis, by Sample Type, 2024 to 2034
Table 49: East Asia Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 50: East Asia Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 51: East Asia Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 52: East Asia Market Value (US$ Mn) Analysis, by Principle, 2018 to 2023
Table 53: East Asia Market Value (US$ Mn) Analysis, by Principle, 2024 to 2034
Table 54: East Asia Market Value (US$ Mn) Opportunity Analysis, by Principle, 2024 to 2034
Table 55: East Asia Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 56: East Asia Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 57: East Asia Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 58: East Asia Market Value (US$ Mn) Analysis, by Sample Type, 2018 to 2023
Table 59: East Asia Market Value (US$ Mn) Analysis, by Sample Type, 2024 to 2034
Table 60: East Asia Market Value (US$ Mn) Opportunity Analysis, by Sample Type, 2024 to 2034
Table 61: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 62: South Asia & Oceania Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 63: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 64: South Asia & Oceania Market Value (US$ Mn) Analysis, by Principle, 2018 to 2023
Table 65: South Asia & Oceania Market Value (US$ Mn) Analysis, by Principle, 2024 to 2034
Table 66: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Principle, 2024 to 2034
Table 67: South Asia & Oceania Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 68: South Asia & Oceania Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 69: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 70: South Asia & Oceania Market Value (US$ Mn) Analysis, by Sample Type, 2018 to 2023
Table 71: South Asia & Oceania Market Value (US$ Mn) Analysis, by Sample Type, 2024 to 2034
Table 72: South Asia & Oceania Market Value (US$ Mn) Opportunity Analysis, by Sample Type, 2024 to 2034
Table 73: MEA Market Value (US$ Mn) Analysis, by Country, 2018 to 2023
Table 74: MEA Market Value (US$ Mn) Analysis, by Country, 2024 to 2034
Table 75: MEA Market Value (US$ Mn) Opportunity Analysis, by Country, 2024 to 2034
Table 76: MEA Market Value (US$ Mn) Analysis, by Principle, 2018 to 2023
Table 77: MEA Market Value (US$ Mn) Analysis, by Principle, 2024 to 2034
Table 78: MEA Market Value (US$ Mn) Opportunity Analysis, by Principle, 2024 to 2034
Table 79: MEA Market Value (US$ Mn) Analysis, by Test Type, 2018 to 2023
Table 80: MEA Market Value (US$ Mn) Analysis, by Test Type, 2024 to 2034
Table 81: MEA Market Value (US$ Mn) Opportunity Analysis, by Test Type, 2024 to 2034
Table 82: MEA Market Value (US$ Mn) Analysis, by Sample Type, 2018 to 2023
Table 83: MEA Market Value (US$ Mn) Analysis, by Sample Type, 2024 to 2034
Table 84: MEA Market Value (US$ Mn) Opportunity Analysis, by Sample Type, 2024 to 2034
More Insights, Lesser Cost (-50% off)
Insights on import/export production,
pricing analysis, and more – Only @ Fact.MR
List Of Figures
Figure 01: Global Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 02: Global Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 03: Global Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 04: Global Market Incremental $ Opportunity, 2024 to 2034
Figure 05: Global Market Share and BPS Analysis by Principle, 2024 & 2034
Figure 06: Global Market Y-o-Y Growth Projections by Principle, 2024 to 2034
Figure 07: Global Market Attractiveness Analysis by Principle, 2024 to 2034
Figure 08: Global Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 09: Global Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 10: Global Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 11: Global Market Share and BPS Analysis by Sample Type, 2024 & 2034
Figure 12: Global Market Y-o-Y Growth Projections by Sample Type, 2024 to 2034
Figure 13: Global Market Attractiveness Analysis by Sample Type, 2024 to 2034
Figure 14: Global Market Share and BPS Analysis by Region, 2024 & 2034
Figure 15: Global Market Y-o-Y Growth Projections by Region, 2024 to 2034
Figure 16: Global Market Attractiveness Analysis by Region, 2024 to 2034
Figure 17: North America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 18: North America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 19: North America Market Value Y-o-Y Growth and Forecast, 2034
Figure 20: North America Market Incremental $ Opportunity, 2024 to 2034
Figure 21: North America Market Share Analysis by Country, 2024 & 2034
Figure 22: North America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 23: North America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 24: North America Market Share and BPS Analysis by Principle, 2024 & 2034
Figure 25: North America Market Y-o-Y Growth Projections by Principle, 2024 to 2034
Figure 26: North America Market Attractiveness Analysis by Principle, 2024 to 2034
Figure 27: North America Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 28: North America Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 29: North America Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 30: North America Market Share and BPS Analysis by Sample Type, 2024 & 2034
Figure 31: North America Market Y-o-Y Growth Projections by Sample Type, 2024 to 2034
Figure 32: North America Market Attractiveness Analysis by Sample Type, 2024 to 2034
Figure 33: Latin America Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 34: Latin America Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 35: Latin America Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 36: Latin America Market Incremental $ Opportunity, 2024 to 2034
Figure 37: Latin America Market Share Analysis by Country, 2024 & 2034
Figure 38: Latin America Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 39: Latin America Market Attractiveness Analysis by Country, 2024 to 2034
Figure 40: Latin America Market Share and BPS Analysis by Principle, 2024 & 2034
Figure 41: Latin America Market Y-o-Y Growth Projections by Principle, 2024 to 2034
Figure 42: Latin America Market Attractiveness Analysis by Principle, 2024 to 2034
Figure 43: Latin America Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 44: Latin America Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 45: Latin America Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 46: Latin America Market Share and BPS Analysis by Sample Type, 2024 & 2034
Figure 47: Latin America Market Y-o-Y Growth Projections by Sample Type, 2024 to 2034
Figure 48: Latin America Market Attractiveness Analysis by Sample Type, 2024 to 2034
Figure 49: Europe Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 50: Europe Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 51: Europe Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 52: Europe Market Incremental $ Opportunity, 2024 to 2034
Figure 53: Europe Market Share Analysis by Country, 2024 & 2034
Figure 54: Europe Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 55: Europe Market Attractiveness Analysis by Country, 2024 to 2034
Figure 56: Europe Market Share and BPS Analysis by Principle, 2024 & 2034
Figure 57: Europe Market Y-o-Y Growth Projections by Principle, 2024 to 2034
Figure 58: Europe Market Attractiveness Analysis by Principle, 2024 to 2034
Figure 59: Europe Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 60: Europe Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 61: Europe Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 62: Europe Market Share and BPS Analysis by Sample Type, 2024 & 2034
Figure 63: Europe Market Y-o-Y Growth Projections by Sample Type, 2024 to 2034
Figure 64: Europe Market Attractiveness Analysis by Sample Type, 2024 to 2034
Figure 65: East Asia Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 66: East Asia Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 67: East Asia Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 68: East Asia Market Incremental $ Opportunity, 2024 to 2034
Figure 69: East Asia Market Share Analysis by Country, 2024 & 2034
Figure 70: East Asia Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 71: East Asia Market Attractiveness Analysis by Country, 2024 to 2034
Figure 72: East Asia Market Share and BPS Analysis by Principle, 2024 & 2034
Figure 73: East Asia Market Y-o-Y Growth Projections by Principle, 2024 to 2034
Figure 74: East Asia Market Attractiveness Analysis by Principle, 2024 to 2034
Figure 75: East Asia Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 76: East Asia Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 77: East Asia Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 78: East Asia Market Share and BPS Analysis by Sample Type, 2024 & 2034
Figure 79: East Asia Market Y-o-Y Growth Projections by Sample Type, 2024 to 2034
Figure 80: East Asia Market Attractiveness Analysis by Sample Type, 2024 to 2034
Figure 81: South Asia & Oceania Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 82: South Asia & Oceania Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 83: South Asia & Oceania Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 84: South Asia & Oceania Market Incremental $ Opportunity, 2024 to 2034
Figure 85: South Asia & Oceania Market Share Analysis by Country, 2024 & 2034
Figure 86: South Asia & Oceania Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 87: South Asia & Oceania Market Attractiveness Analysis by Country, 2024 to 2034
Figure 88: South Asia & Oceania Market Share and BPS Analysis by Principle, 2024 & 2034
Figure 89: South Asia & Oceania Market Y-o-Y Growth Projections by Principle, 2024 to 2034
Figure 90: South Asia & Oceania Market Attractiveness Analysis by Principle, 2024 to 2034
Figure 91: South Asia & Oceania Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 92: South Asia & Oceania Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 93: South Asia & Oceania Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 94: South Asia & Oceania Market Share and BPS Analysis by Sample Type, 2024 & 2034
Figure 95: South Asia & Oceania Market Y-o-Y Growth Projections by Sample Type, 2024 to 2034
Figure 96: South Asia & Oceania Market Attractiveness Analysis by Sample Type, 2024 to 2034
Figure 97: MEA Market Value (US$ Mn) Historical Analysis, 2018 to 2023
Figure 98: MEA Market Value (US$ Mn) Forecast and Analysis, 2024 to 2034
Figure 99: MEA Market Value Y-o-Y Growth and Forecast, 2018 to 2034
Figure 100: MEA Market Incremental $ Opportunity, 2024 to 2034
Figure 101: MEA Market Share Analysis by Country, 2024 & 2034
Figure 102: MEA Market Y-o-Y Growth Projection by Country, 2024 to 2034
Figure 103: MEA Market Attractiveness Analysis by Country, 2024 to 2034
Figure 104: MEA Market Share and BPS Analysis by Principle, 2024 & 2034
Figure 105: MEA Market Y-o-Y Growth Projections by Principle, 2024 to 2034
Figure 106: MEA Market Attractiveness Analysis by Principle, 2024 to 2034
Figure 107: MEA Market Share and BPS Analysis by Test Type, 2024 & 2034
Figure 108: MEA Market Y-o-Y Growth Projections by Test Type, 2024 to 2034
Figure 109: MEA Market Attractiveness Analysis by Test Type, 2024 to 2034
Figure 110: MEA Market Share and BPS Analysis by Sample Type, 2024 & 2034
Figure 111: MEA Market Y-o-Y Growth Projections by Sample Type, 2024 to 2034
Figure 112: MEA Market Attractiveness Analysis by Sample Type, 2024 to 2034
Know thy Competitors
Competitive landscape highlights only certain players
Complete list available upon request
- FAQs -
How big is the rapid influenza diagnostic test market size in 2024?
The global market for rapid influenza diagnostic tests stands at US$ 1.13 billion in 2024.
What is the projected revenue from rapid influenza diagnostic tests for 2034?
By 2034, worldwide revenue from rapid influenza diagnostic test sales is projected to reach US$ 2.61 billion.
How fast are rapid influenza diagnostic tests sales projected to increase?
The market has been forecasted to increase at 8.7% CAGR through 2034.
What is the sales forecast for the market in North America?
The market in North America are forecasted to increase at 8.7% CAGR from 2024 to 2034.
At what rate is the market projected to expand in East Asia?
The market in East Asia is projected to expand at a CAGR of 9.2% from 2024 to 2034.
What are the projections for the market in South Korea?
Sales of rapid influenza diagnostic tests in South Korea are forecasted to rise at a CAGR of 10.6% from 2024 to 2034.
Rapid Influenza Diagnostic Test Market